| For: | Barbalata CI, Tefas LR, Achim M, Tomuta I, Porfire AS. Statins in risk-reduction and treatment of cancer. World J Clin Oncol 2020; 11(8): 573-588 [PMID: 32879845 DOI: 10.5306/wjco.v11.i8.573] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i8/573.htm |
| Number | Citing Articles |
| 1 |
Xiaolin Jia, Ye Lu, Zili Xu, Qingqing Mu. Impact of statin use on breast cancer recurrence and mortality before and after diagnosis: a systematic review and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1256747
|
| 2 |
T. A. Nalbandian, I. M. Antonyan. SIGNIFICANCE OF AGE AND CONCOMITANT PATHOLOGY WITH METABOLIC DISORDERS IN THE CARCINOGENESIS OF PROSTATE CANCER. Bulletin of Problems Biology and Medicine 2024; 1(4) doi: 10.29254/2077-4214-2024-4-175-63-74
|
| 3 |
Duaa S. Nasereldin, Launia J. White, David O. Hodge, Lewis R. Roberts, Tushar Patel, Samuel O. Antwi. Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk. Digestive and Liver Disease 2022; 54(7) doi: 10.1016/j.dld.2021.12.002
|
| 4 |
Antonio Rodríguez-Miguel, Encarnación Fernández-Antón, Diana Barreira-Hernández, Luis A. García-Rodríguez, Miguel Gil, Alberto García-Lledó, Francisco J. De Abajo. Statins and Colorectal Cancer Risk: A Population-Based Case-Control Study and Synthesis of the Epidemiological Evidence. Journal of Clinical Medicine 2022; 11(6) doi: 10.3390/jcm11061528
|
| 5 |
Marissa R Diggs, Triin Umbleja, Sara McCallum, Markella V Zanni, Sarah M Chu, Kathleen V Fitch, Gerald S Bloomfield, Judith S Currier, Esteban Martinez, Philip E Castle, Aya Awwad, Mamta K Jain, Roger Bedimo, Bronwyn Hendricks, Jose Narrea, Vincente Estrada, Jorge Pinto, Judith A Aberg, Carlos D Malvestutto, Carl J Fichtenbaum, Michael T Lu, Heather J Ribaudo, Pamela S Douglas, Steven K Grinspoon. Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial. The Lancet HIV 2025; 12(4) doi: 10.1016/S2352-3018(24)00345-X
|
| 6 |
Archana Mishra, Pooja Gupta. Handbook of Oncobiology: From Basic to Clinical Sciences. 2024; doi: 10.1007/978-981-99-6263-1_77
|
| 7 |
Archana Mishra, Pooja Gupta. Handbook of Oncobiology: From Basic to Clinical Sciences. 2023; doi: 10.1007/978-981-99-2196-6_77-1
|
| 8 |
Fatemeh Zarei, Zahra Salimi, Motahareh Zeinivand, Nastaran Zamani, Reza Bahrani. An Overview of the Antioxidant, Anti-inflammatory, and Anticancer Effects of Statins. Anti-Cancer Agents in Medicinal Chemistry 2026; 26(7) doi: 10.2174/0118715206377993251115050803
|
| 9 |
Slight SH, Hyder SM. Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target?. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.1081151
|
| 10 |
Ali Amiri, Wei Xu, Qihuang Zhang, Jae H. Jeong, Stephen J. Freedland, Neil E. Fleshner, Antonio Finelli, Robert J. Hamilton. The association between statin use, genetic variation, and prostate cancer risk. Prostate Cancer and Prostatic Diseases 2025; 28(4) doi: 10.1038/s41391-025-00964-x
|
| 11 |
Wenfang Li, Jianxiong Xu, Yuxuan Long, Han Zhang, Xiaojuan Rong, Zhengding Su. Emerging roles of the metabolic regulator 3-hydroxy-3-methylglutaryl coenzyme-CoA reductase in human cancers: From biology to therapeutics. Genes & Diseases 2026; 13(4) doi: 10.1016/j.gendis.2025.101945
|
| 12 |
Thomas Cash, Hunter C. Jonus, Maya Tsvetkova, Jan H. Beumer, Arhanti Sadanand, Jasmine Y. Lee, Curtis J. Henry, Dolly Aguilera, R. Donald Harvey, Kelly C. Goldsmith. A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors. Pediatric Blood & Cancer 2023; 70(8) doi: 10.1002/pbc.30405
|
| 13 |
. 2022; doi: 10.70675/dd61653azf828z4163zb82ez3a51f5c99328
|
| 14 |
Nur Salwani Bakar, Nik Nur Hakimah Nik Salleh. Exploring the potential role of monocarboxylate transporters in statin-induced mitochondrial dysfunction: a new perspective on statin-related myopathy and anti-cancer strategies. Future Journal of Pharmaceutical Sciences 2025; 11(1) doi: 10.1186/s43094-025-00896-2
|
| 15 |
Sambamoorthy Unnam, Arehalli S. Manjappa, Bhanoji Rao Muddana Eswara, Ahmad Salawi, Purushottam Gunti. Liposomal Melphalan: Approach to obtain improved plasma stability, pharmacokinetics, and in vitro and in vivo anticancer efficacy in combination with liposomal simvastatin against mouse RPMI-8226 multiple myeloma model. Journal of Drug Delivery Science and Technology 2022; 73 doi: 10.1016/j.jddst.2022.103479
|
| 16 |
Jood Hashem, Farah Alsukhni, Hassan Abushukair, Mahmoud Ayesh. The Effect of Atorvastatin on Oncogenic miRNAs in Hematological Malignancies: A Central Study. Biomolecules 2024; 14(12) doi: 10.3390/biom14121559
|
| 17 |
Yi Zhou, Vishakha Sharma, Xiaoyu Li, Rajeev K. Singla, Ankush Kumar, Ashishkumar Kyada, Suhas Ballal, Deepak Nathiya, Apurva Koul, Mohammad Khalid, Monica Gulati, Sandeep Arora, Tapan Behl, Joachim Kavalakatt, Bairong Shen, Anupam Bishayee. Targeting Pathways Implicated in Cholesterol Metabolism for Novel Cancer Therapy. Cancers 2026; 18(3) doi: 10.3390/cancers18030428
|
| 18 |
Stefan Mark Nidorf, Abdallah Almaghraby, Yehia Saleh, Venkat R. Katkoori, Zain ul Abideen, Harvey L. Bumpers, Dorothy R. Pathak, George S. Abela. Cholesterol Crystals in Atherosclerosis and Other Related Diseases. Contemporary Cardiology 2023; doi: 10.1007/978-3-031-41192-2_22
|
| 19 |
Fung-Chang Sung, Ying-Chin Jong, Chih-Hsin Muo, Chih-Cheng Hsu, Wen-Chen Tsai, Yueh-Han Hsu. Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.815882
|
| 20 |
D. E. Bobkov, A. V. Lukacheva, A. I. Gorb, G. G. Poljanskaya. Role of Rho Family Small GTPases in the Regulation of Normal and Pathological Processes. Cell and Tissue Biology 2024; 18(3) doi: 10.1134/S1990519X24700159
|
| 21 |
Hasan Ali Farhan, Israa Fadhil Yaseen, Mohammed Alomar, Daniel Lenihan, Susan Dent, Alexander R. Lyon. Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.979631
|
| 22 |
Chenliang Ge, Zhiyuan Jiang, Binghua Long, Qingjian Lu, Yan He. Associations between cardiovascular diseases and cancer mortality: insights from a retrospective cohort analysis of NHANES data. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-18498-7
|
| 23 |
A. V. Smirnov, O. V. Gruzdeva, E. V. Pomeshkin, A. I. Bragin-Maltsev. Dyslipidemia and risk of prostate canсer in patients with urologic diseases. Fundamental and Clinical Medicine 2022; 7(1) doi: 10.23946/2500-0764-2022-7-1-42-52
|
| 24 |
Jenna R. James, Johnathan Curd, Jennifer C. Ashworth, Mays Abuhantash, Martin Grundy, Claire H. Seedhouse, Kenton P. Arkill, Amanda J. Wright, Catherine L. R. Merry, Alexander Thompson. Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24044235
|
| 25 |
Magdalena Wujak, Anna Kozakiewicz, Anna Ciarkowska, Joanna I. Loch, Magdalena Barwiolek, Zuzanna Sokolowska, Marcin Budny, Andrzej Wojtczak. Assessing the Interactions of Statins with Human Adenylate Kinase Isoenzyme 1: Fluorescence and Enzyme Kinetic Studies. International Journal of Molecular Sciences 2021; 22(11) doi: 10.3390/ijms22115541
|
| 26 |
Martin G. Houston, Úna McMenamin, Brian Johnston, Ronald D. McDowell, Carmel M. Hughes, Peter Murchie, Chris R. Cardwell. Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case‐control studies. British Journal of Clinical Pharmacology 2023; 89(9) doi: 10.1111/bcp.15759
|
| 27 |
Nazli Güllü, Janice Smith, Pia Herrmann, Ulrike Stein. MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer. Nutrients 2022; 14(22) doi: 10.3390/nu14224792
|
| 28 |
Laura Antonucci, Michael Karin. The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer Prevention Research 2024; 17(4) doi: 10.1158/1940-6207.CAPR-23-0423
|
| 29 |
Alex Liu, Wei Rao, Kymberly D. Watt. Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle. Liver Transplantation 2026; 32(1) doi: 10.1097/LVT.0000000000000509
|
| 30 |
Danuta Szkutnik-Fiedler, Edyta Szałek, Filip Otto, Andrzej Czyrski, Marta Karaźniewicz-Łada, Anna Wolc, Edmund Grześkowiak, Konrad Lewandowski, Agnieszka Karbownik. Pharmacokinetic interaction between regorafenib and atorvastatin in rats. Pharmacological Reports 2024; 76(5) doi: 10.1007/s43440-024-00570-z
|
| 31 |
Göran Walldius. High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines. Expert Review of Cardiovascular Therapy 2025; 23(9) doi: 10.1080/14779072.2025.2543535
|
| 32 |
Te-Chuan Chen, Chen-Wei Huang, Chih-Yu Lo, Cheng-Nan Chen, Shun-Fu Chang, Yih-Yuan Chen. Suppression of SREBP-1 Expression by Simvastatin Decreases Visfatin-Induced Chemoresistance to Sunitinib in Human Renal Carcinoma 786-O Cells. Life 2022; 12(11) doi: 10.3390/life12111890
|
| 33 |
Jisha Pillai U, Anindita Ray, Meenu Maan, Mainak Dutta. Repurposing drugs targeting metabolic diseases for cancer therapeutics. Drug Discovery Today 2023; 28(9) doi: 10.1016/j.drudis.2023.103684
|
| 34 |
Ruby Kasana, Christy Thomas, Gaurav Das, Munlima Hazarika, Krishna Undela. Statin use and risk of cancer. Annals of Oncology Research and Therapy 2023; 3(1) doi: 10.4103/aort.aort_34_22
|
| 35 |
Casie S. Kubota, Stephanie L. Myers, Toni T. Seppälä, Richard A. Burkhart, Peter J. Espenshade. In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency. Molecular Metabolism 2024; 85 doi: 10.1016/j.molmet.2024.101964
|
| 36 |
Sara Khan, Bintul Huda, Farida Bhurka, Rajashree Patnaik, Yajnavalka Banerjee. Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes. International Journal of Molecular Sciences 2025; 26(17) doi: 10.3390/ijms26178429
|
| 37 |
Natalia Piekuś-Słomka, Lavinia Patricia Mocan, Rezarta Shkreli, Cristiana Grapă, Kinga Denkiewicz, Oliwia Wesolowska, Miroslaw Kornek, Zeno Spârchez, Artur Słomka, Rareș Crăciun, Tudor Mocan. Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer. Cancers 2023; 15(20) doi: 10.3390/cancers15205100
|
| 38 |
Adeel A. Butt, Peng Yan, Obaid S. Shaikh, Muzna I. Lone, Ahmed Demirci, Salih Akgun, Amyn A. Malik, Khurram Nasir. Statin use and severe, critical, or fatal outcomes among individuals with coronavirus disease 2019. IJID Regions 2026; 20 doi: 10.1016/j.ijregi.2026.100946
|
| 39 |
Fung-Chang Sung, Yi-Ting Yeh, Chih-Hsin Muo, Chih-Cheng Hsu, Wen-Chen Tsai, Yueh-Han Hsu. Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study. Cancers 2022; 14(3) doi: 10.3390/cancers14030825
|
| 40 |
Iulia Rus, Mihaela Tertiș, Cristina Barbălată, Alina Porfire, Ioan Tomuță, Robert Săndulescu, Cecilia Cristea. An Electrochemical Strategy for the Simultaneous Detection of Doxorubicin and Simvastatin for Their Potential Use in the Treatment of Cancer. Biosensors 2021; 11(1) doi: 10.3390/bios11010015
|
| 41 |
Unnam Sambamoorthy, Arehalli S. Manjappa, Bhanoji Rao Muddana Eswara, Arun Kumar Sanapala, Naidu Nagadeepthi. Vitamin E Oil Incorporated Liposomal Melphalan and Simvastatin: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable Melphalan and Anticancer Activity in Combination with Simvastatin Against Multiple Myeloma. AAPS PharmSciTech 2021; 23(1) doi: 10.1208/s12249-021-02177-6
|
| 42 |
Samhita De, Sourav Paul, Anirban Manna, Chirantan Majumder, Koustav Pal, Nicolette Casarcia, Arijit Mondal, Sabyasachi Banerjee, Vinod Kumar Nelson, Suvranil Ghosh, Joyita Hazra, Ashish Bhattacharjee, Subhash Chandra Mandal, Mahadeb Pal, Anupam Bishayee. Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies. Cancers 2023; 15(3) doi: 10.3390/cancers15030993
|
| 43 |
Amjad Z. Alrosan, Ghaith B. Heilat, Zeinab Y. Al Subeh, Khaled Alrosan, Alaa F. Alrousan, Amro K. Abu-Safieh, Nuwar S. Alabdallat. The effects of statin therapy on brain tumors, particularly glioma: a review. Anti-Cancer Drugs 2023; 34(9) doi: 10.1097/CAD.0000000000001533
|
| 44 |
Akihiro Matsukawa, Takafumi Yanagisawa, Kensuke Bekku, Mehdi Kardoust Parizi, Ekaterina Laukhtina, Jakob Klemm, Sever Chiujdea, Keiichiro Mori, Shoji Kimura, Jun Miki, Benjamin Pradere, Juan Gomez Rivas, Giorgio Gandaglia, Takahiro Kimura, Veeru Kasivisvanathan, Guillaume Ploussard, Philip Cornford, Shahrokh F. Shariat, Pawel Rajwa. Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis. European Urology Oncology 2024; 7(3) doi: 10.1016/j.euo.2023.10.010
|
| 45 |
Zhenhan Zhu, Wenxia Jiang, Jiehao Zhou, Alexander Robert Maldeney, Jingru Liang, Jing Yang, Wei Luo. The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B‐Cell Lymphoma. Cancer Medicine 2024; 13(21) doi: 10.1002/cam4.70342
|
| 46 |
Yara E Elakkad, Shimaa Nabil Senousy Mohamed, Nermeen Z Abuelezz. Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis. Breast Cancer: Targets and Therapy 2021; doi: 10.2147/BCTT.S336712
|
| 47 |
Asmara Ahmad, Sadia Javed, Shumaila Kiran. Statin as Repurposed Drug in Ovarian Cancer: A Comprehensive Review. Current Pharmaceutical Design 2023; 29(27) doi: 10.2174/1381612829666230913113808
|
| 48 |
D. E. Bobkov, A. V. Lukacheva, A. I. Gorb, G. G. Poljanskaya. The role of the Rho family small GTPases in regulation of normal and pathological processes. Цитология 2024; 66(1) doi: 10.31857/S0041377124010012
|
| 49 |
Sneha Tripathi, Ekta Gupta, Sanjeev Galande. Statins as anti‐tumor agents: A paradigm for repurposed drugs. Cancer Reports 2024; 7(5) doi: 10.1002/cnr2.2078
|
| 50 |
Zhenzhou Xu, Liang Huang, Tao Dai, Xiaming Pei, Longzheng Xia, Gongqian Zeng, Mingji Ye, Kan Liu, Fuhua Zeng, Weiqing Han, Shusuan Jiang. SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer. OncoTargets and Therapy 2021; doi: 10.2147/OTT.S315813
|
| 51 |
Samar A. Dewidar, Omar Hamdy, Ahmed Eltantawy, Mohamed El-Mesery, Amal M. El Gayar, Moetaza M. Soliman. Effect of concomitant use of pitavastatin with neoadjuvant chemotherapy protocols in breast cancer patients: A randomized controlled clinical trial. Saudi Pharmaceutical Journal 2022; 30(10) doi: 10.1016/j.jsps.2022.07.011
|
| 52 |
Armin Khaghani, Karamali Kasiri, Saeid Heidari-Soureshjani, Catherine M.T. Sherwin, Hossein Mardani-Nafchi. A Systematic Review and Meta-analysis of the Relationship between Statin Intake
and Esophageal Cancer. Anti-Cancer Agents in Medicinal Chemistry 2024; 24(14) doi: 10.2174/0118715206292712240522043350
|
| 53 |
Anam Kamal, Julie Boerner, Hadeel Assad, Wei Chen, Michael S. Simon. The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer. International Journal of Molecular Sciences 2024; 25(17) doi: 10.3390/ijms25179587
|
| 54 |
Sabya Sachi Das, Sandeep Kumar Singh, P.R.P. Verma, Rekha Gahtori, Belay Zeleke Sibuh, Kavindra Kumar Kesari, Niraj Kumar Jha, Sugapriya Dhanasekaran, Vijay Kumar Thakur, Ling Shing Wong, Sinouvassane Djearamane, Piyush Kumar Gupta. Polyester nanomedicines targeting inflammatory signaling pathways for cancer therapy. Biomedicine & Pharmacotherapy 2022; 154 doi: 10.1016/j.biopha.2022.113654
|
| 55 |
Samin Ghorbani Moghadam, Mehrshad Ebrahimpour, Seyedeh Hoda Alavizadeh, Prashant Kesharwani, Amirhossein Sahebkar. The association between oxidized low-density lipoprotein and cancer: An emerging targeted therapeutic approach?. Bioorganic & Medicinal Chemistry Letters 2024; 106 doi: 10.1016/j.bmcl.2024.129762
|
| 56 |
|
| 57 |
Mohamed Y. Zaky, Chuanwen Fan, Huan Zhang, Xiao-Feng Sun. Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance. Cancers 2023; 15(19) doi: 10.3390/cancers15194787
|
| 58 |
Talar S. Habeshian, Yu‐Hsiang Shu, Kimberly L. Cannavale, Jeff M. Slezak, Gary W. Chien, Stephen K. Vandeneeden, Chun R. Chao. Exposure to statins post localized prostate cancer diagnosis and risk of metastasis among men who did not receive curative prostate cancer treatment. Cancer Reports 2023; 6(3) doi: 10.1002/cnr2.1749
|
| 59 |
Nikoletta Szemerédi, Zsuzsanna Schelz, Dária Antónia Horvath, Bálint Rácz, András G. Szatmári, Hiba F. Muddather, Noémi Bózsity, István Zupkó, Gabriella Spengler. Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines. Pharmaceutics 2024; 16(7) doi: 10.3390/pharmaceutics16070877
|
| 60 |
James C. Davis, Susan E. Waltz. The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism. Genes 2024; 15(7) doi: 10.3390/genes15070953
|
| 61 |
Mithila Tennakoon, Waruna Thotamune, John L. Payton, Ajith Karunarathne. CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions. Journal of Biological Chemistry 2023; 299(11) doi: 10.1016/j.jbc.2023.105269
|
| 62 |
Zahra Shaghaghi, Maryam Alvandi, Soghra Farzipour, Mohammad Reza Dehbanpour, Sahar Nosrati. A review of effects of atorvastatin in cancer therapy. Medical Oncology 2022; 40(1) doi: 10.1007/s12032-022-01892-9
|
| 63 |
Mitali Pandey, Grace Cuddihy, Jacob A. Gordon, Michael E. Cox, Kishor M. Wasan. Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer. Pharmaceutics 2021; 13(9) doi: 10.3390/pharmaceutics13091509
|
| 64 |
Ana Salomé Correia, Lara Marques, Nuno Vale. The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin. Current Issues in Molecular Biology 2023; 45(4) doi: 10.3390/cimb45040218
|
| 65 |
Karim Samy El-Said, Merna Saied Attia, Bassant Ezzat Abdelmoaty, Elsayed Ibrahim Salim. Synergistic antitumor effects of atorvastatin and chemotherapies: In vitro and in vivo studies. Biochemical and Biophysical Research Communications 2025; 742 doi: 10.1016/j.bbrc.2024.151078
|
| 66 |
Vijay Kumar, John H. Stewart. Obesity, bone marrow adiposity, and leukemia: Time to act. Obesity Reviews 2024; 25(3) doi: 10.1111/obr.13674
|
| 67 |
Patricia Guerrero-Ochoa, Sergio Rodríguez-Zapater, Alberto Anel, Luis Mariano Esteban, Alejandro Camón-Fernández, Raquel Espilez-Ortiz, María Jesús Gil-Sanz, Ángel Borque-Fernando. Prostate Cancer and the Mevalonate Pathway. International Journal of Molecular Sciences 2024; 25(4) doi: 10.3390/ijms25042152
|
| 68 |
Göran Walldius. High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines. Expert Review of Cardiovascular Therapy 2025; 23(9) doi: 10.1080/14779072.2025.2543537
|
| 69 |
Magdalena Staszczak. Fungal Secondary Metabolites as Inhibitors of the Ubiquitin–Proteasome System. International Journal of Molecular Sciences 2021; 22(24) doi: 10.3390/ijms222413309
|
| 70 |
Alexa Rose León, Michael Risk, William A. Ricke, Jinn-ing Liou, David F. Jarrard, Kyle A. Richards. Understanding the role of statin use on advanced prostate cancer outcomes: Does the statin type, cumulative dose, or duration impact survival?. Urologic Oncology: Seminars and Original Investigations 2026; 44(2) doi: 10.1016/j.urolonc.2025.11.004
|
| 71 |
Prasoona Karra, Maci Winn, Svenja Pauleck, Alicja Bulsiewicz‐Jacobsen, Lacie Peterson, Adriana Coletta, Jennifer Doherty, Cornelia M. Ulrich, Scott A. Summers, Marc Gunter, Sheetal Hardikar, Mary C. Playdon. Metabolic dysfunction and obesity‐related cancer: Beyond obesity and metabolic syndrome. Obesity 2022; 30(7) doi: 10.1002/oby.23444
|
| 72 |
Stefan A. Lange, Christoph Schliemann, Christiane Engelbertz, Jannik Feld, Lena Makowski, Joachim Gerß, Patrik Dröge, Thomas Ruhnke, Christian Günster, Holger Reinecke, Jeanette Köppe. Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis. Cancers 2023; 15(20) doi: 10.3390/cancers15204966
|
| 73 |
Daniela Mengual, Luz Elena Medrano, Wendy Villamizar-Villamizar, Estefanie Osorio-Llanes, Evelyn Mendoza-Torres, Samir Bolívar. Novel Effects of Statins on Cancer via Autophagy. Pharmaceuticals 2022; 15(6) doi: 10.3390/ph15060648
|
| 74 |
Chiharu Miyajima, Yurika Hayakawa, Yasumichi Inoue, Mai Nagasaka, Hidetoshi Hayashi. HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ. Pharmaceuticals 2022; 15(8) doi: 10.3390/ph15081015
|
| 75 |
Khatereh Anbari, Mehdi Mohammadian Amiri, Saeid Heidari-Soureshjani, Catherine MT Sherwin, Karamali Kasiri. A Systematic Review and Meta-analysis on the Role of Statins in the Prevention of
Mortality Following Pancreatic Cancer. Anti-Cancer Agents in Medicinal Chemistry 2023; 23(19) doi: 10.2174/1871520623666230824095226
|
| 76 |
A.V. Smirnov, E.B. Brusina, Yu.A. Magaryll, L.A. Gordeeva. Epidemiological analysis of prostate cancer risk factors. Profilakticheskaya meditsina 2022; 25(8) doi: 10.17116/profmed20222508175
|
| 77 |
Wei-Ming Cheng, Po-Chen Li, Minh Tran-Binh Nguyen, Yu-Teng Lin, Yu-Tang Huang, Tai-Shan Cheng, Thi-Huong Nguyen, Thu-Ha Tran, Tzu-Yi Huang, Thu-Huyen Hoang, Sin-Yu Chen, Yu-Chieh Chu, Chih-Wei Wu, Ming-Fen Lee, Yi-Shiou Chiou, Hsiao-Sheng Liu, Yi-Ren Hong, Peter Mu-Hsin Chang, Yu‑Feng Hu, Ying-Chih Chang, Jin-Mei Lai, Chi-Ying F. Huang. Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03712-2
|
| 78 |
Emanuela Chiarella, Clelia Nisticò, Anna Di Vito, Helen Linda Morrone, Maria Mesuraca. Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs. Biomedicines 2022; 10(5) doi: 10.3390/biomedicines10051146
|
| 79 |
Athiban Inbarajan, Mubeena S, Alan Mathew Punnoose, Giri GVV, Anusha D, Jasline David J. Effects of Simvastatin on Gene Expression and Alkaline Phosphatase Activity in the MG-63 Cell Line Treated With Hyperglycemia for Bone Regeneration . Cureus 2024; doi: 10.7759/cureus.55482
|
| 80 |
Yarden Ariav, Samah Hayek, Thomas Cantore, Neel Sanghvi, Lital N. Adler, Naama Darzi, Lipika R. Pal, David Robert Crawford, Tomer Malleron, Josh Silverbeck, Eliane Yardeni, Emma Hajaj, Efrat Ben-Zeev, Sanju Sinha, Shahar Ziman, Amir Shlomai, Sergey Malitsky, Maxim Itkin, Smadar Levin-Zaidman, Inna Goliand, Omer Goldman, Hila Tishler, Alexander Brandis, Tevie Mehlman, Yuri Kuznetsov, Noga Kozer, Karen Shamash, Ella Itzhaki, Neta Ben-Chaim Moskovits, Dean Ranmar, Salomon M. Stemmer, Shay Ben-Shachar, Eytan Ruppin, Ayelet Erez. PDE5A Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking through a Noncanonical cGMP-Dependent Pathway. Cancer Research 2026; 86(19) doi: 10.1158/0008-5472.CAN-26-1818
|
| 81 |
Beniamin Oskar Grabarek, Dariusz Boroń, Emilia Morawiec, Piotr Michalski, Veronica Palazzo-Michalska, Łukasz Pach, Barbara Dziuk, Magdalena Świder, Nikola Zmarzły. Crosstalk between Statins and Cancer Prevention and Therapy: An Update. Pharmaceuticals 2021; 14(12) doi: 10.3390/ph14121220
|
| 82 |
Sara Mikhael, Abdullah Kurdi, Nathalie Khoueiry-Zgheib, Roula Tahtouh, Rihab Nasr, George Hilal, Chien-Feng Li. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells. PLOS ONE 2024; 19(3) doi: 10.1371/journal.pone.0298127
|
| 83 |
Alice C. Ceacareanu, Shanria D. Jolly, George K. Nimako, Zachary A. P. Wintrob. Statin Type and Cancer Outcomes in Patients with Diabetes Type 2 and Solid Tumors. Journal of Research in Pharmacy Practice 2021; 10(1) doi: 10.4103/jrpp.JRPP_21_3
|
| 84 |
Maria Błaszczyk, Agata Kozioł, Anna Palko-Łabuz, Kamila Środa-Pomianek, Olga Wesołowska. Modulators of cellular cholesterol homeostasis as antiproliferative and model membranes perturbing agents. Biochimica et Biophysica Acta (BBA) - Biomembranes 2023; 1865(6) doi: 10.1016/j.bbamem.2023.184163
|